Veeva raised $4M in VC to build CRM for life sciences and currently has a $21B market cap. It's one of the 15 or so best exits of the last decade. I agree that

Veeva raised $4M in VC to build CRM for life sciences and currently has a $21B market cap. It's one of the 15 or so best exits of the last decade. I agree that comparing biology today to transistors in the 1950s might seem hubristic. But even if you don't buy that, I would bet on the notion that there are pretty massive opportunities at the intersection of tech and bio. I work in Boston and there's tremendous activity in the life science space, as traditionally defined. Doesn't seem crazy to believe that market could support many billion-dollar companies that build picks and shovels.